Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 30, 2002

View Archived Issues

Drug pipeline for cystic fibrosis

Biovitrum presents novel 5-HT6 antagonists for obesity, diabetes and CNS disorders

Novel PPARalpha/gamma receptor agonists in early development at Roche

Guilford researchers prepare and test new series of NAALADase inhibitors

Prinomastat monotherapy in low-risk myelodysplastic syndrome

New data on the HDAC inhibitor MS-275 in leukemia

Efficacy and safety of tipifarnib in leukemia and other hematological disorders

Clinical results reported for lonafarnib in hematological malignancies

Epothilone B effective and well tolerated in advanced breast cancer

Axovan enters research collaboration with Biolipox to discover antiinflammatory drugs

Cephalon reacquires modafinil rights in key E.U. countries

Xcytrin enters pivotal trial for treatment of brain metastases in NSCLC patients

NeoPharm seeks FDA guidance on IL-13-PE38 trial design and registration plan

Pfizer and Eyetech form collaboration to develop and commercialize Macugen

License agreement for Befar in South Korea

Phase I trial of BI-K0376 completes enrollment

TBC-MVA smallpox vaccine enters phase I testing

Neurocrine Biosciences and Pfizer enter global agreement for indiplon

STTR grant supports antibody research at Acorda and Mayo Clinic for treatment of MS

Progenics commences phase III program for methylnaltrexone

Novartis files NDA for Certican for prevention of kidney and heart transplant rejection

Positive opinion in E.U. for Lilly's teriparatide in established osteoporosis

Restrictions on the use of new lung cancer drug

Monoclonal antibodies targeting CD40 claimed by Kirin Brewery

GSK identifies new series of human PPAR agonists and potential uses

New CRF receptor ligands designed by BMS

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...